Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2013

Conditions
Hyperovulation Induction for Assisted Reproduction Treatment
Interventions
DRUG

r-hCG

r-hCG(250mcg) injection subcutaneously

Trial Locations (3)

Unknown

Cha Medical school Boondang-Cha hospital, Seongnam

Cha Medical school Gangnam-Cha hospital, Seoul

Kwandong university medical school Cheil hospital, Seoul

All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

NCT01718119 - Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel | Biotech Hunter | Biotech Hunter